EXPLORE BY CATEGORY
WHAT IS MULTIPLE MYELOMA?
SIGNS & SYMPTOMS OF MULTIPLE MYELOMA
HOW IS MULTIPLE MYELOMA DIAGNOSED?
TYPES OF MULTIPLE MYELOMA
February 2, 2019
There are so many myeloma phrases, terminology and acronyms that things can get incredibly confusing. Let’s talk about Relapsed Myeloma (sort of self explanatory) and Refractory Myeloma (need a refresher course on this one!). Relapsed Myeloma According to Dr. Sagar Lonial, MD of the Winship Cancer Institute at Emory University, Relapsed Myeloma “specifically includes patients[...]
January 28, 2019
The first vaccine ever used was in 1786 for smallpox. Since then, vaccines have become a commonplace way to help prevent disease and most are familiar with how they work. For these types of vaccines, a person is injected with an inactive state of a specific virus in order to aid the person’s immune system[...]
October 27, 2018
Stem cell collection is the first step of the stem cell transplant process. In myeloma, patients typically use their own stem cells for transplant. This is called an autologous transplant, or “auto” transplant. In order to obtain stem cells for your transplant, you will go through a stem cell collection, or “harvest” process. While the[...]
October 27, 2018
Neutropenia is when a person has little to no neutrophils, a type of white blood cell. This means that your body’s immune system is not strong enough to fight infections, bacteria, or other foreign antibodies. When one is neutropenic, it can lead to serious infections because the body has no way to fight it. Neutropenia can occur during[...]
July 6, 2018
Myeloma genetics is an important piece of the myeloma puzzle. If we know what type of myeloma we have, we can see if there are patterns of treatments received and resulting outcomes. The most commonly run genetics test is called the FISH test. A fluorescence in situ hybridization test (FISH) maps out the genetic material[...]
June 29, 2017
June 20, 2017
No two myeloma patients are the same. That being said, every patient, no matter their case, should learn and be aware of their specific cancer. They key to achieving that knowledge is patient literacy. According to David Somekh, Director of European Health Futures Forum, “…to be literate in their disease means that the patient understands[...]
Get Started Today.
Find a Clinical Trial that's Right for You
Thanks to our site sponsors: